Merck

MRK · Xetra · EUR

€136.90Change from previous close: +1.82%Absolute change: +€2.45

Close · October 2, 2026

At a glance

Revenue growth
−0.26%
2025 vs 2024
Net income growth
−6.09%
2025 vs 2024
Net margin
12.4%
2024: 13.1%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Balance sheet · Annual
Item20252024202320222021
Total assets51,52751,59648,49548,53545,362
Current assets13,23013,45012,39312,20110,982
Cash and equivalents2,7402,5171,9821,8541,899
Short-term investments597559398203100
Receivables4,7704,8994,9055,0344,772
Inventory4,5624,4844,6374,6323,900
Net property, plant and equipment9,94010,0259,0568,2047,217
Goodwill17,93419,10717,84518,38917,004
Other intangible assets7,6606,3496,5517,3357,612
Long-term investments772964808675615
Current liabilities9,04211,2958,6999,51410,432
Accounts payable1,4221,5021,7701,5961,542
Long-term debt10,2056,3728,8468,8347,928
Total debt11,95210,2719,86410,398—
Total liabilities22,86721,60721,74022,53023,946
Total equity (incl. minority)28,66029,98926,75526,00521,416
Retained earnings24,01522,42020,63418,81116,610
Minority interest68.075.075.078.078.0